Cosmetic Formulation and Document Explainer

What a good one includes

• A simplified high-level executive summary that translates complex chemical compounds into their common consumer-facing names and primary functions.
• A clear breakdown of regulatory restrictions or concentration limits for target markets like the EU, US FDA, or Health Canada.
• An ingredient-by-ingredient safety and allergen analysis, highlighting any components that require specific warning labels or safety testing.
• A plain-language breakdown of who owns the intellectual property of the final formulation based on your manufacturer's agreement.
• A list of supply chain vulnerabilities, such as hard-to-source raw materials or ingredients prone to rapid oxidation and spoilage.
• A clear list of recommended next steps, including necessary stability testing, safety assessments, or contract amendments to discuss with your lab.

Common mistakes to avoid

• Relying on the manufacturer's verbal promises instead of getting a written, plain-language breakdown of who owns the rights to the manufacturing process and formula.
• Overlooking the difference between raw ingredient trade names and their actual INCI (International Nomenclature of Cosmetic Ingredients) names on the safety sheet, leading to incorrect packaging labels.
• Ignoring regional concentration limits for active ingredients during the early formulation review, resulting in costly reformulations later when trying to export.
• Failing to clarify minimum order quantities or lead times associated with specific proprietary ingredients mentioned in the supplier contract.

Frequently asked questions